Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1957 1
1961 3
1962 1
1963 4
1964 5
1965 10
1966 9
1967 7
1968 12
1969 7
1970 14
1971 8
1972 10
1973 16
1974 20
1975 18
1976 21
1977 23
1978 26
1979 32
1980 27
1981 35
1982 31
1983 38
1984 48
1985 51
1986 55
1987 54
1988 38
1989 43
1990 50
1991 62
1992 63
1993 64
1994 81
1995 53
1996 75
1997 93
1998 96
1999 92
2000 109
2001 90
2002 84
2003 92
2004 97
2005 89
2006 85
2007 94
2008 133
2009 134
2010 144
2011 169
2012 149
2013 194
2014 191
2015 218
2016 227
2017 206
2018 210
2019 231
2020 220
2021 260
2022 241
2023 246
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

4,852 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a PCSK9-LDLR disruptor peptide with in vivo function.
Brousseau ME, Clairmont KB, Spraggon G, Flyer AN, Golosov AA, Grosche P, Amin J, Andre J, Burdick D, Caplan S, Chen G, Chopra R, Ames L, Dubiel D, Fan L, Gattlen R, Kelly-Sullivan D, Koch AW, Lewis I, Li J, Liu E, Lubicka D, Marzinzik A, Nakajima K, Nettleton D, Ottl J, Pan M, Patel T, Perry L, Pickett S, Poirier J, Reid PC, Pelle X, Seepersaud M, Subramanian V, Vera V, Xu M, Yang L, Yang Q, Yu J, Zhu G, Monovich LG. Brousseau ME, et al. Among authors: nakajima k. Cell Chem Biol. 2022 Feb 17;29(2):249-258.e5. doi: 10.1016/j.chembiol.2021.08.012. Epub 2021 Sep 20. Cell Chem Biol. 2022. PMID: 34547225 Free article.
Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Matsumoto K, Oda K, Shoji K, Hanai Y, Takahashi Y, Fujii S, Hamada Y, Kimura T, Mayumi T, Ueda T, Nakajima K, Takesue Y. Matsumoto K, et al. Among authors: nakajima k. Pharmaceutics. 2022 Feb 23;14(3):489. doi: 10.3390/pharmaceutics14030489. Pharmaceutics. 2022. PMID: 35335866 Free PMC article. Review.
European Association for Endoscopic Surgery (EAES) consensus on Indocyanine Green (ICG) fluorescence-guided surgery.
Cassinotti E, Al-Taher M, Antoniou SA, Arezzo A, Baldari L, Boni L, Bonino MA, Bouvy ND, Brodie R, Carus T, Chand M, Diana M, Eussen MMM, Francis N, Guida A, Gontero P, Haney CM, Jansen M, Mintz Y, Morales-Conde S, Muller-Stich BP, Nakajima K, Nickel F, Oderda M, Parise P, Rosati R, Schijven MP, Silecchia G, Soares AS, Urakawa S, Vettoretto N. Cassinotti E, et al. Among authors: nakajima k. Surg Endosc. 2023 Mar;37(3):1629-1648. doi: 10.1007/s00464-023-09928-5. Epub 2023 Feb 13. Surg Endosc. 2023. PMID: 36781468 Free PMC article.
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ, Aguirre C, Kakuda K, Beck G, Nakanishi H, Kimura Y, Shimma S, Nabekura K, Hideshima M, Doi J, Yamaguchi K, Nakajima K, Wadayama T, Hayakawa H, Baba K, Ogawa K, Takeuchi T, Badawy SMM, Murayama S, Nagano S, Goto Y, Miyanoiri Y, Nagai Y, Mochizuki H, Ikenaka K. Choong CJ, et al. Among authors: nakajima k. Acta Neuropathol. 2023 May;145(5):573-595. doi: 10.1007/s00401-023-02555-3. Epub 2023 Mar 20. Acta Neuropathol. 2023. PMID: 36939875 Free PMC article.
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Among authors: nakajima k. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
Simultaneous determination of intracellular nucleotide sugars.
Nakajima K, Taniguchi N. Nakajima K, et al. 2021 Oct 20 [updated 2022 Mar 23]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. 2021 Oct 20 [updated 2022 Mar 23]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. PMID: 37590625 Free Books & Documents. Review. No abstract available.
Supersaturation-Dependent Formation of Amyloid Fibrils.
Goto Y, Noji M, Nakajima K, Yamaguchi K. Goto Y, et al. Among authors: nakajima k. Molecules. 2022 Jul 19;27(14):4588. doi: 10.3390/molecules27144588. Molecules. 2022. PMID: 35889461 Free PMC article. Review.
Cardiac 123I-mIBG Imaging in Heart Failure.
Verschure DO, Nakajima K, Verberne HJ. Verschure DO, et al. Among authors: nakajima k. Pharmaceuticals (Basel). 2022 May 25;15(6):656. doi: 10.3390/ph15060656. Pharmaceuticals (Basel). 2022. PMID: 35745574 Free PMC article. Review.
Nuclear Cardiology Data Analyzed Using Machine Learning.
Nakajima K, Maruyama K. Nakajima K, et al. Ann Nucl Cardiol. 2022;8(1):80-85. doi: 10.17996/anc.22-00164. Epub 2022 Aug 31. Ann Nucl Cardiol. 2022. PMID: 36540177 Free PMC article. Review.
4,852 results